NCT04825977

Brief Summary

The rationale of this study in UGIB patients is to assess whether the prediction of mortality and morbidity using AIMS65 score improves when used in combination with RDW in the emergency department setting.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
348

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 29, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

1.7 years

First QC Date

March 29, 2021

Last Update Submit

March 29, 2021

Conditions

Keywords

Emergency Department, Upper GI Bleed, Risk Stratification, Mortality, Red Cell Distribution Width, AIMS65 Score, Receiver Observer Characteristic Curve

Outcome Measures

Primary Outcomes (1)

  • predictive accuracy of addition of RDW to AIMS65 SCORE in determining the 30-day mortality of patients presenting to the ED with symptoms of UGIB

    30 days

Interventions

Risk Statification of patients presenting with upper gastrointestinal bleeding to the emergency department using AIMS65 score and Red cell Distribution Width.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult (\>18 years of age) patients presenting with UGIB to the ED of Jubilee Mission Medical College and Research Institute during the 18 months' time period were included in the study. The diagnosis of UGIB was based on patients' presentations, including coffee ground vomitus, hematemesis, melena, and blood in nasogastric aspirate. These patients were considered eligible for the study.

You may qualify if:

  • All patients presenting to ED with UGIB
  • Age more than 18 years of age

You may not qualify if:

  • Patients not consenting to study
  • Patients with known hematological disorders
  • Patients in which endoscopy or blood transfusion is done outside
  • Patients in which RDW value and laboratory parameters required for AIMS65 score are not available.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jubilee Mission Medical College and Research Institute

Thrissur, Kerala, 680027, India

Location

MeSH Terms

Conditions

Gastrointestinal HemorrhageEmergencies

Interventions

Erythrocyte Indices

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Intervention Hierarchy (Ancestors)

Hematologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesBlood Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Siju V Abraham, MD

    Jubilee Mission Medical College

    STUDY CHAIR
  • Rajeev P C, MD

    Jubilee Mission Medical College

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Junior Resident

Study Record Dates

First Submitted

March 29, 2021

First Posted

April 1, 2021

Study Start

August 1, 2018

Primary Completion

March 31, 2020

Study Completion

October 31, 2020

Last Updated

April 1, 2021

Record last verified: 2021-03

Locations